JPWO2021207150A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021207150A5
JPWO2021207150A5 JP2023504152A JP2023504152A JPWO2021207150A5 JP WO2021207150 A5 JPWO2021207150 A5 JP WO2021207150A5 JP 2023504152 A JP2023504152 A JP 2023504152A JP 2023504152 A JP2023504152 A JP 2023504152A JP WO2021207150 A5 JPWO2021207150 A5 JP WO2021207150A5
Authority
JP
Japan
Prior art keywords
immune cells
population
ifnγ
cancer
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023504152A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521519A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/025906 external-priority patent/WO2021207150A1/fr
Publication of JP2023521519A publication Critical patent/JP2023521519A/ja
Publication of JPWO2021207150A5 publication Critical patent/JPWO2021207150A5/ja
Pending legal-status Critical Current

Links

JP2023504152A 2020-04-06 2021-04-06 キメラ抗原受容体を発現し低減した炎症性サイトカインシグナル伝達を有する遺伝子改変された免疫細胞 Pending JP2023521519A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063005684P 2020-04-06 2020-04-06
US63/005,684 2020-04-06
PCT/US2021/025906 WO2021207150A1 (fr) 2020-04-06 2021-04-06 Cellules immunitaires génétiquement modifiées exprimant un récepteur antigénique chimérique et ayant une signalisation de cytokine pro-inflammatoire réduite

Publications (2)

Publication Number Publication Date
JP2023521519A JP2023521519A (ja) 2023-05-24
JPWO2021207150A5 true JPWO2021207150A5 (fr) 2024-04-12

Family

ID=78022619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023504152A Pending JP2023521519A (ja) 2020-04-06 2021-04-06 キメラ抗原受容体を発現し低減した炎症性サイトカインシグナル伝達を有する遺伝子改変された免疫細胞

Country Status (10)

Country Link
US (1) US20230149465A1 (fr)
EP (1) EP4132973A4 (fr)
JP (1) JP2023521519A (fr)
KR (1) KR20230019419A (fr)
CN (1) CN115698062A (fr)
AU (1) AU2021251113A1 (fr)
CA (1) CA3173490A1 (fr)
IL (1) IL297034A (fr)
WO (1) WO2021207150A1 (fr)
ZA (1) ZA202210919B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114350665A (zh) * 2022-01-19 2022-04-15 上海优替济生生物医药有限公司 IFN-γ抑制剂及其用途
US20230256065A1 (en) * 2022-02-16 2023-08-17 Elena RUSYN Autologous stem cell vaccine and methods
EP4269432A1 (fr) * 2022-04-26 2023-11-01 Universite de Rouen Normandie Production d'anticorps thérapeutiques par le phaeodctylum tricornutum des micro-algues
CN117965633A (zh) * 2024-04-01 2024-05-03 北京双赢科创生物科技有限公司 一种IFNγ受体敲除的CAR-T细胞的制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574205A (en) * 1989-07-25 1996-11-12 Cell Genesys Homologous recombination for universal donor cells and chimeric mammalian hosts
WO2004034988A2 (fr) * 2002-10-16 2004-04-29 Amgen Inc. Anticorps humains neutralisants anti-ifn-$g(g) utilises comme inhibiteurs selectifs des voies de ifn-$g(g)
US11091543B2 (en) * 2015-05-07 2021-08-17 Swedish Orphan Biovitrum Ag Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
CN112004823A (zh) * 2018-02-02 2020-11-27 宾夕法尼亚大学董事会 表达嵌合抗原受体的修饰的单核细胞/巨噬细胞/树突细胞和在蛋白质聚集体相关的疾病和失调中的用途
CN110615843B (zh) * 2018-06-20 2023-05-09 上海隆耀生物科技有限公司 一种包含第三信号受体的嵌合抗原受体及其应用
GB201814203D0 (en) * 2018-08-31 2018-10-17 King S College London Engineered regulatory t cell

Similar Documents

Publication Publication Date Title
US11932698B2 (en) Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof
JP2020517295A5 (fr)
JP2019525956A5 (fr)
JP2021501570A5 (fr)
JP2020513828A5 (fr)
US20200038443A1 (en) Multi-function and multi-targeting car system and methods for use thereof
JP2017513818A5 (fr)
JP2020517259A5 (fr)
RU2015109631A (ru) Способ и композиции для клеточной иммунотерапии
WO2020143631A1 (fr) Association pour immunothérapie cellulaire
US11725053B2 (en) Chimeric antigen receptors comprising a human transferrin epitope sequence
JP2015527070A5 (fr)
WO2021057906A1 (fr) Cellule effectrice immunitaire exprimant il-15
WO2020057641A1 (fr) Cellule exprimant la chimiokine et son utilisation
JPWO2020047452A5 (fr)
US20220127570A1 (en) Immune effector cell and use thereof
CA3132202A1 (fr) Recepteurs antigeniques chimeriques anti-dll3 humanises et leurs utilisations
WO2021027785A1 (fr) Cellule effectrice immunitaire pour co-exprimer un récepteur de chimiokine
CA3132201A1 (fr) Recepteurs antigeniques chimeriques anti-claudine 18.2 humanises et utilisations associees
JP2023538012A (ja) 免疫細胞機能の改善
US20210079111A1 (en) Cd19-cd20 bispecific and dual passway car-t and methods for use thereof
JPWO2021207150A5 (fr)
JPWO2020051493A5 (fr)
KR20230155521A (ko) 면역 세포 기능의 향상
JPWO2021071962A5 (fr)